Frances Austin, MD

Dr. Austin is a member of the American Society of Pediatric Hematology-Oncology, American Society of Hematology, Children’s Oncology Group, American Society of Clinical Oncology and International Society of Paediatric Oncology. 

• C Yang, F Austin, H Richard, M Idowa, V Williamson, F Sabato, A Ferrerira-Gonzalex, SA Turner. Lynch Syndromrome Associated ultra hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome. Cold Spring Harb Mol Case Study. 2019 Oct 23:5(5). pii: a003863. doi: 10.1101/mcs.a003863.
• F Austin, U Oyarbide, G Massey, M Grimes, S Corey. Synonymous mutation in TP53 results in cryptic splice site affecting its DNA binding site in an adolescent with two primary sarcomas. Pediatric Blood & Cancer. Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26584. Epub 2017 May 5.
• PL Wagner, F Austin, M Zenati, A Mavanur, L Ramalingam, H Jones, M P Holtzman, S Ahrendt, AH Zureikat, JF Pingpank, HJ Zeh, DL Bartlett, H Choudry. Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis. Ann Surg Oncol. 2016 May;23(5):1587-93. doi: 10.1245/s10434-015-5037-7.
• D Magge, MS Zenati, F Austin, A Mavanur, M Sathaiah, L Ramalingam, H Jones, AH Zureikat, M Holtzman, S Ahrendt, J Pingpank, HJ Zeh, DL Bartlett, HA Choudry. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014 Apr;21(4):1159-65. doi: 10.1245/s10434-013-3358-y.
• P Thirunavukarasu, M Sathaiah, MC Gorry , ME O'Malley, R Ravindranathan, F Austin, SH Thorne, ZS Guo, DL Bartlett. A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis. Mol Ther. 2013 May;21(5):1024-33. doi: 10.1038/mt.2013.27.
• PL Wagner, F Austin, U Maduekwe, A Mavanur, L Ramalingam, HL Jones, MP Holtzman, SA Ahrendt, AH Zureikat, JF Pingpank, HJ Zeh, DL Bartlett, HA Choudry. Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival. Ann Surg Oncol. 2013 Apr;20(4):1056-62. doi: 10.1245/s10434-012-2791-7.
• PL Wagner, F Austin, M Sathaiah, D Magge, U Maduekwe, L Ramalingam, HL Jones, MP Holtzman, SA Ahrendt, AH Zureikat, JF Pingpank, HJ Zeh 3rd, DL Bartlett, HA Choudry. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013 Feb;20(2):506-14. doi: 10.1245/s10434-012-2627-5
• F Austin, A Mavanur, M Sathaiah, J Steel, D Lanzner, L Ramalingam, M Holtzman, S Ahrent, J Pingpank, HJ Zeh, DL Bartlett, HA Choudry. Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol. 2012 May; 19(5):1386-93.
• M Sathaiah, P Thirunavukkarasu, ME O'Malley, MA Kavanagh, R Ravindranathan, F Austin, ZS Guo, DL Bartlett. Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer. Cancer Gene Ther. 2012 March; 19(3):192-201.
• ZS Guo, V Parimi, ME O'Malley, P Thirunavukarasu, M Sathaiah, F Austin, DL Bartlett. The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. Gene Ther. 2010 December; 17(12):1465-75.
• MF Ziauddin, ZS Guo, ME O’Malley, F Austin, PJ Popovic, MA Kavanagh, J Li, M Sathaiah, P Thirunavukkarasu, B Fang, YJ Lee, and DL Bartlett. TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal Cancer. Gene Ther. 2010 April; 17(4):550–559.